Alan Edmund Walts

This profile gathers the share dealings of Alan Edmund Walts in Eloxx Pharmaceuticals, Inc., where the filings describe the role as board member. The record holds 3 filings, for trades running from 1 December 2021 to 24 January 2025.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 28 January 2025 came the latest disclosure, an option exercise in Eloxx Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.